Vizient Launches Direct to Employer Solutions for Health Care Systems

To meet the increasing demand from self-insured employers looking to contract with health care provider networks, Vizient, Inc. announced the launch of its Direct to Employer Solutions for health care systems.

Ashfield Launches EmerGENE to Support Biotechs’ Commercialization Activities

Ashfield, part of UDG Healthcare plc, has announced the launch of EmerGENE, a global end-to-end cell and gene therapy network approach which promises to support small and midsize biotechs with the commercialization of their discoveries

Arete Pharmacy Network and PPOK Create PSAO Named AlignRx

Arete Pharmacy Network and Pharmacy Providers of Oklahoma to create AlignRx, a pharmacy services administrative organization (PSAO) strategically aligned with the needs of a continuously evolving pharmacy landscape

Pandion Optimization Alliance Acquires New Source GPO

Pandion Optimization Alliance (Pandion), a rapidly growing player in the group purchasing organization (GPO) space, announced it will acquire New Source GPO, which has 12,000+ membership base in the Southeast as well as around the country

Global Issues Driving US Healthcare Trends in 2021 and 2022

For the remainder of 2021 through the end of 2022, the key trends explored here will reflect the transition from pre-to post–COVID-19 healthcare environment and the related health reengineering by key stakeholders, global influences on domestic decision-making, as well as the effects of evolving federal or state government policies.

EVERSANA Partners With Resverlogix to Commercialize Breakthrough Cardiovascular/CKD drug

In preparation for launch, Resverlogix will utilize EVERSANA’s fully integrated commercialization services

Blues Plans Pharmacy Solutions Venture Evio Targets Outcomes-Based Drug Contracts

Evio will work to improve medication affordability and patients’ clinical outcomes and medication experiences. The five plans in total provide coverage to more than 20 million members across the United States.